MENU
GANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gain Therapeutics (GANX) Ownership - Who owns Gain Therapeutics?
Profile
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
32
Web
https://www.gaintherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
44.56M
P/E Ratio
N/A
Total Cash
12.05M
Projected Growth
N/A
Total Debt
769.41K
Revenue
N/A
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash/Share
0.45
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GANX
Capitalization
44.6M
P/E Ratio
N/A
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash
12M
Total Cash/Share
0.45
Total Debt
769K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
8.91M
P/B Ratio
5.00
Cash Flow
N/A
Earnings
-1.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.6K
Current Ratio
2.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-21.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-150.14
Shares Held By Institutions
3.82M
Shares Outstanding - Current
26.5M
Total Liabilities
5.46M
Total Volume MTD
N/A
Value
-1
Gain YTD
-48.545
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
32
Web
https://www.gaintherapeutics.com